Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies

OBJECTIVE: Many autoantibodies are known to be associated with SLE, although their role in clinical practice is limited because of low sensitivity and weak associations with clinical manifestations. There has been great interest in the discovery of new autoantibodies to use in clinical practice. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunekreef, Tammo, Limper, Maarten, Melchers, Rowena, Mathsson-Alm, Linda, Dias, Jorge, Hoefer, Imo, Haitjema, Saskia, van Laar, Jacob M, Otten, Henny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562534/
https://www.ncbi.nlm.nih.gov/pubmed/34725184
http://dx.doi.org/10.1136/lupus-2021-000531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562534/
https://www.ncbi.nlm.nih.gov/pubmed/34725184
http://dx.doi.org/10.1136/lupus-2021-000531

Ejemplares similares